Call for Session, Presentation, and Short Course Abstracts
Read Abstract Details | Submit
Abstract Submission Deadline: Wednesday April 22, 2026
Notification: Week of June 1, 2026
Final PowerPoint Presentations Due: September 29, 2026
Conference Dates: October 19-20, 2026
Questions: Contact Jessica.Roman@DIAglobal.org
Do you work at the intersection of real-world data (RWD) and real-world evidence (RWE), from data sourcing and evidence generation to informing decisions by regulators, payers, healthcare systems, providers, patients, or policymakers across drugs, biologics, or devices? If so, DIA wants to hear from you! Join leaders and innovators at the DIA Real-World Evidence Conference, October 19-20 in Bethesda, MD. This year’s program will spotlight innovative applications of RWE and feature practical insights from organizations using real-world evidence to shape healthcare decision-making and advance cutting-edge research.
To build a comprehensive and forward-looking program, we invite abstract submissions from professionals who are pushing the boundaries in their respective fields. Share your ideas, experiences, and innovations that highlight emerging trends, novel approaches, and best practices in RWE. We welcome submissions in the following formats:
- Presentations: 15-20-minute presentation to be bundled with other presentations to create a session (1 author/speaker)
- Sessions: 60-75-minute total session (1 author/speaker + 2 additional speakers)
- Workshop: 60-75-minute workshop delivered in an interactive/simulation or role-playing format (1 author/speaker + 2 additional speakers)
- Short Course(s) will be conducted virtually approximately 1 week prior to the live RWE Conference. The duration of the course is 3.5 hours. Proposals should go beyond traditional presentations and focus on interactive learning. Please specify in your submission:
- Names of speakers (at least 2) to include representation from multiple sectors (e.g., industry, academia, regulatory, payer, and service providers)
- Engagement strategies (e.g., interactive exercises, small-group learning, etc.)
With a diverse audience spanning academia, payers, regulators, biopharma and medical device companies, health authorities, advocacy groups, and service providers, the Program Committee welcomes a wide range of topics, including, but not limited to, those outlined below. We especially encourage submissions that share real-world use cases and practical lessons learned, whether the outcomes were successes, challenges, or somewhere in between.
Interest Areas:
- Data Infrastructure, Quality, and Standards
- Emerging RWD Sources and Global Systems
- Governance, Privacy, and Global Harmonization
- Innovative Study Designs Leveraging RWD, RW Approaches
- Patient-involvement in the Development, Regulation, and Safety of Medicines
- Public-private Partnerships
- Technology and Methodological Innovations
- Transparency of RWE
- Use of RWD in Market Access / HTA
- Use of RWD in Post Marketing Settings
- Use of RWD/E in Clinical Development and Regulatory Decision Making
- Other
Abstract Details and Guidelines
